NEW YORK and LONDON, August 4th, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will present at the 36th Annual Canaccord|Genuity Growth Conference on August 10th, 2016, in Boston, Massachusetts. The company is scheduled to present at 1:00 p.m. EDT.
